Clinical Trials Directory

Trials / Unknown

UnknownNCT04820166

The Effect of Monitoring PVP on Clinical Outcomes in Patients With PH

The Effect of Monitoring Portal Venous Pressure on Clinical Outcomes in Patients With Portal Hypertension: a Prospective, Single-center, Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

The complications associated with portal hypertension in cirrhosis are the main cause of death in patients with cirrhosis. The level of portal venous pressure is closely related to the prognosis of patients. HVPG (hepatic venous pressure gradient) is the "gold standard" for predicting portal venous pressure and an important indicator for evaluating the efficacy of NSBBS. However, monitoring HVPG has many limitations,and the clinical application is also limited to a certain extent. Therefore, this study intends to clarify the guiding value of monitoring portal venous pressure in the clinical diagnosis and treatment of portal hypertension patients through a single-center, prospective and observational study. Therefore, this study intends to clarify the guiding value of monitoring portal venous pressure in the clinical diagnosis and treatment of portal hypertension patients through a single-center, prospective and observational study. At the same time, to explore the correlation between HVPG and PPG in cirrhosis patients at different stages and different etiologies, and to evaluate the role of spleen stiffness in predicting the severity of esophageal and gastric varices in patients with portal hypertension, and to find biomarkers to predict the risk of complications related to portal hypertension.

Conditions

Interventions

TypeNameDescription
OTHERmonitoring portal pressure gradient or hepatic venous pressure gradientmeasuring portal pressure gradient or hepatic venous pressure gradient regularly

Timeline

Start date
2021-03-12
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2021-03-29
Last updated
2021-03-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04820166. Inclusion in this directory is not an endorsement.